BRADLEY SAENGER - 23 Feb 2023 Form 4 Insider Report for Tonix Pharmaceuticals Holding Corp. (TNXP)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TNXP	Stock Option	Award	$0	+200,000		$0.000000	200,000	23 Feb 2023	Common Stock	200,000	$0.7310	Direct	F1, F2
transaction	TNXP	Stock Option	Award	$0	+200,000		$0.000000	200,000	23 Feb 2023	Common Stock	200,000	$0.9140	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
F2	The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.